Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254067 · ClinicalTrials.gov registry record
Enterprise 2 Vascular Reconstruction Device
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 10
- Enrollment target
NCT05254067 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 10 participants.
The verdict
NCT05254067 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.
Interventions
- DEVICE Codman Enterprise 2 Vascular Reconstruction Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2026-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254067
The ClinicalTrials.gov registry entry for NCT05254067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Codman Enterprise 2 Vascular Reconstruction Device is the first listed.
NCT05254067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05254067 about?
NCT05254067 is a clinical study titled "Enterprise 2 Vascular Reconstruction Device". The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.
What is the current status of trial NCT05254067?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-02-28. Estimated completion is 2026-01-05.
What interventions are being tested in trial NCT05254067?
The interventions under investigation include: Codman Enterprise 2 Vascular Reconstruction Device (DEVICE).
Who is sponsoring clinical trial NCT05254067?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.